Attacking metastatic tumours in the brain
Targeting HER3 could cripple metastatic cancers that have spread to the brain...
List view / Grid view
Targeting HER3 could cripple metastatic cancers that have spread to the brain...
A multi-institutional team based at Massachusetts General Hospital (MGH) has discovered how a potential treatment strategy for Huntington disease (HD) produces its effects, verified its action in human cells and identified a previously unknown deficit in neural stem cells from patients with HD.
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed an innovative nanoplatform that allows them to effectively deliver RNAi agents to the sites of cancer and suppress tumour growth...
15 June 2016 | By Victoria White, Digital Content Producer
An analysis of changes in the intestinal microbial population during the first three years of life has revealed some of the impacts of antibiotic exposure...
25 May 2016 | By Victoria White, Digital Content Producer
The findings may lead to new therapeutic strategies and suggest limitations to therapies designed to eliminate amyloid plaques from Alzheimer's patient's brains...